Haisco Pharmaceutical Group Co., Ltd. (SZSE: 002653)
Health Care · Pharmaceuticals · CN
CN¥62.18
+1.42% today · +17.5% 1Y
Haisco Pharmaceutical Group Co., Ltd. (SZSE: 002653) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $10.28B and employs 5,597 people.
Over the last twelve months the share price has gained 17.5%, trading between 42.38 and 80.83.
Tweenvest scores Haisco Pharmaceutical Group Co., Ltd. across four factors: quality 69/100, value 39/100, growth 51/100, dividend 29/100. Its strongest factor is quality.
002653 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $10.28B
- Revenue (TTM)
- $807.11M
- P/E
- 73.92
- EPS
- 0.84
- Dividend yield
- 0.85%
- Beta (5Y)
- -0.19
- 52-week high
- CN¥80.83
- 52-week low
- CN¥42.38
- Avg volume (3M)
- —
- Shares outstanding
- 1.11B
- Employees
- 5,597
- Next earnings
- —
About Haisco Pharmaceutical Group Co., Ltd.
Haisco Pharmaceutical Group Co., Ltd., along with its subsidiaries, operates within China, focusing on the research, production, and distribution of a diverse range of pharmaceutical products. Their offerings span various dosage forms, including small and large volume injections, freeze-dried and conventional powder injections, and active pharmaceutical ingredients (APIs). These medications target numerous therapeutic areas such as anti-infectives, digestive system disorders, blood system conditions, nervous system ailments, parenteral nutrition, antibiotics, emergency care, anesthesiology, and oncology. Furthermore, the company provides drugs in tablet, capsule, granule, and ointment forms for cardiovascular health, infectious diseases, digestive issues, central nervous system (CNS) conditions, diabetes, and hepatic diseases. Established in 2000 and based in Shannan, China, the company adopted its current name, Haisco Pharmaceutical Group Co., Ltd., in March 2016, having previously been known as Xizang Haisco Pharmaceutical Group Co., Ltd.
- ISIN
- CNE100001BC7
- Founded
- 2000
- Listed since
- Jan 17, 2012
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Laurus Labs LimitedNSEI: LAURUSLABS | $11.13B | Rs1,984.00 | -1.15% |
| Mankind Pharma LimitedNSEI: MANKIND | $10.87B | Rs2,535.00 | +2.43% |
| Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.SHSE: 600436 | $10.61B | CN¥118.00 | +2.41% |
| Dr. Reddy's Laboratories LimitedBSE: 500124 | $10.35B | Rs1,202.40 | -0.56% |
| Aurobindo Pharma LimitedNSEI: AUROPHARMA | $10.02B | Rs1,676.80 | -2.06% |
| Asymchem Laboratories (Tianjin) Co., Ltd.SZSE: 002821 | $9.93B | CN¥188.62 | +5.79% |
| CSPC Innovation Pharmaceutical Co., Ltd.SZSE: 300765 | $9.80B | CN¥47.19 | +6.89% |
| Sichuan Kelun Pharmaceutical Co., Ltd.SZSE: 002422 | $9.69B | CN¥40.85 | +5.12% |
Figures last refreshed Oct 4, 2026.